ArticleLeukemia2025

DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.

V S S Abhinav Ayyadevara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.